Jennifer L. Taubert, EVP, WWC. Innovative Medicine at JOHNSON & JOHNSON (JNJ), sold 15,000 shares at $263.36 ($4.0M) on 2026-08-17, disclosed to the SEC on 2026-08-18.
Open-market sale of $4.0M JNJ by EVP, WWC. Innovative Medicine. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| JNJ | SELL | 2022-11-23 | $27.2M | — | Filing → |